Newsletter

Chronic Inflammatory Demyelinating Polyneuropathy Market
One of the treatable but rare disorders, CIDP is a result of inflammation in peripheral nerves
Chronic Inflammatory Demyelinating Polyneuropathy Market

More Whitepapers / Newsletters

Pompe Disease Newsletter
Pompe Disease

An autosomal metabolic disorder – Pompe disease results in deterioration of organs and tissues as a consequence of excess accumulation of glycogen in muscle and nerve cells throughout the body. Also c...

Rethinking medtech in Covid times
Rethinking medtech in Covid ti...

COVID-19 transforms healthcare facets at an unprecedented pace. Based on emerging technology, we can be reasonably sure that the bulk of the change will be powered by the digital transformation made p...

Multiple Myeloma Market
Multiple Myeloma

Multiple myeloma (MM) is a cancer of the blood that begins in the bone marrow. In myeloma, plasma cells develop into cancerous myeloma cells. Multiple myeloma is not widespread cancer; however, it has...

Remdesivir In COVID-19
Remdesivir In COVID-19

Remdesivir is a broad-spectrum antiviral drug that has previously demonstrated in vitro and in vivo activity against the viral pathogens MERS and SARS, which are also coronaviruses having structural s...

ASCO: Evolution of Precision Medicine
Let Us Hear From ASCO: Evoluti...

Past decades have witnessed a shift in the focus of researchers and pharma companies towards tailoring the treatment approach and regiment cancer patients are administered. Unlike traditional chemothe...